4D Molecular Therapeutics, Inc. (FDMT) vs Olema Pharmaceuticals, Inc. (OLMA)

4D Molecular Therapeutics, Inc. and Olema Pharmaceuticals, Inc. are both Biotechnology companies. 4D Molecular Therapeutics, Inc. and Olema Pharmaceuticals, Inc. are of similar size ($807.1M and $791.0M). Olema Pharmaceuticals, Inc. has the higher net margin (0.00% vs −194.7%) and the higher return on invested capital (0.00% vs −186.9%). Across the 14 metrics below, 4D Molecular Therapeutics, Inc. leads on 7 and Olema Pharmaceuticals, Inc. on 7.

Valuation

Metric FDMT OLMA Biotechnology median
P/E n/m n/m 7.88
P/S 11.05 n/m 11.47
P/B 2.49 2.12 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 7.34 n/m 10.73
Earnings yield (18.18%) (24.23%) (28.84%)
Free cash flow yield (15.34%) (18.05%) (23.03%)

Profitability

Metric FDMT OLMA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (214.24%) 0.00% 0.00%
Net margin (194.74%) 0.00% 0.00%
Free cash flow margin (169.51%) 0.00% 0.00%
Return on equity (43.25%) (52.74%) (57.72%)
Return on assets (37.09%) (47.10%) (49.22%)
Return on invested capital (186.91%) 0.00% 0.00%

Growth

Metric FDMT OLMA Biotechnology median
Revenue growth (TTM) 278,712.12% — 5.64%
EPS growth (last fiscal year) 18.79% 15.00% —
Revenue growth, 5-year CAGR 44.32% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FDMT OLMA Biotechnology median
Debt to equity 0.05 0.01 0.00
Current ratio 8.03 8.86 4.73
Net debt to EBITDA 2.52 2.82 0.96

Dividend

Metric FDMT OLMA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FDMT OLMA Biotechnology median
Market cap 807.12m 790.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack